Mandate

Vinge has advised Hexatronic Group AB (publ) in connection with a directed share issue

November 09, 2021 Capital Markets and Public M&A

Vinge has advised Hexatronic Group AB (publ) in connection with a directed share issue whereby the company receives approximately SEK 550 million in gross issue proceeds.

The share issue was carried out as an accelerated book building process and directed to selected Swedish and international institutional investors. Hexatronic intends to use the net proceeds from the directed share issue to increase Hexatronics financial flexibility for further acquisitions, to establish a new plant for micro duct production in the US that will be up and running in Q3 2022, for investments in increased production capacity based on high demand mostly from growth markets, and for general corporate purposes to support growth opportunities. ABG Sundal Collier AB and Pareto Securities AB acted as joint bookrunners in connection with the directed share issue. Vinge acted as legal adviser to Hexatronic.

Hexatronic Group AB (publ) is a group that develops, markets and delivers products, components and system solutions with the main focus on the fiber optic market, and offers a wide range of innovative system and product solutions mainly for passive fiber optic infrastructure.

Vinge’s team has consisted of Anders Strid, Edin Agic and Adrian Filipovic.

 

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025